DGPharma SRL
0.2 FTEThe score of DGPharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -33 % Total assets +32 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
DGPharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
- Year ended 31 Dec 2024filed on 22 Jul 2025
- Year ended 31 Dec 2023filed on 05 Jul 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 16 Jun 2022
DGPharma's financial analysis
- Solvency22.5%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of DGPharma
DGPharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0508.925.544
- VAT number
- BE0508925544
- Peppol
- Registered · 0208:0508925544 · as of 08 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Dec 2012
- Registered office
- 9051 Ghent
- Size
- Micro · 0.2 FTE
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
DGPharma (SRL) has been based in Ghent since 2012, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 158,798 € and equity of 300,586 €; its revenue is not published. With 0.2 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 22.5%, below the median of its sector (46.0%).
Companies similar to DGPharma
Companies in the same business, of comparable size and area, outside its group.
- GUANG JI Pharmaceutical Belgium sa Business and other management consultancy activities Ottignies-Louvain-la-Neuve · balance sheet 32,994 €
- Deblauwe Business and other management consultancy activities Koksijde · balance sheet 572,138 €
- Benelux Scientific Wholesale of pharmaceutical and medical goods Nazareth-De Pinte · balance sheet €2.90m
- DE Dommel Business and other management consultancy activities Waasmunster · balance sheet 730,988 €
- Aagato Medical Wholesale of pharmaceutical and medical goods Ghent · balance sheet €3.86m
- Extraphar Wholesale of pharmaceutical and medical goods Woluwe-Saint-Lambert · balance sheet 10,258 €
- Tristel Wholesale of pharmaceutical and medical goods Antwerp · balance sheet €1.88m
- Brucare Wholesale of pharmaceutical and medical goods Overijse · balance sheet 903,825 €
Frequently asked questions about DGPharma
What is the revenue of DGPharma?
DGPharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of DGPharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0508925544 for DGPharma, if the company is VAT-registered. Its company number (CBE) is 0508.925.544.
Where is the registered office of DGPharma?
According to the CBE register, the registered office of DGPharma is in 9051 Ghent.
What is the equity of DGPharma?
At the close of the 2025 financial year, the equity of DGPharma amounts to 300,586 €, a solvency of 22.5% of total assets.
How many people work at DGPharma?
0.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages DGPharma?
The register lists 6 active mandates at DGPharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of DGPharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →